In Vivo is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Nancy Dvorin

Managing Editor

Connecticut, US
Nancy Dvorin joined the IN VIVO staff in 1999 to report on emerging life science companies. She has been managing editor of the publication since 2009, and responsible for producing IN VIVO’s insightful coverage of the biopharma, medtech and diagnostics industries. Before joining IN VIVO, Nancy managed library and information services for a number of multinational corporations. She’s delighted that her passion for delivering useful, actionable intelligence to clients has translated well from the information service to the information provider arena.
Set Alert for Articles By Nancy Dvorin

Latest From Nancy Dvorin

In Vivo's Deals Of The Month, February 2018

In Vivo's editors pick January's most significant deals, including Roche's acquisition of Flatiron and Moderna's latest big private fundraising. (Free article.)
Deals Market Intelligence

In Vivo's Deals Of The Month, January 2018

In Vivo's editors pick January's most significant deals, including an alliance of players new to health care and Celgene's big buys. (Free article.)

Deals Market Intelligence

In Vivo's 2017 Deals Of The Year: The Winners Are…

We nominated 15 deals in three categories. You picked the winners.

Deals Market Intelligence

In Vivo Needs Your Feedback!

Please take our brief reader survey to help In Vivo evolve to meet your needs in 2018. No strings attached, and those who complete the survey will be in the running for Amazon gift vouchers.

BioPharmaceutical Medical Device

In Vivo's Top 10 For 2017

Our 10 most-read thought leadership pieces of last year. Not surprisingly, our looks at pricing, reimbursement and patient access scored well. Readers also responded to our deep dives into technology innovation and our conversations with industry leaders. (Free article.)

BioPharmaceutical Medical Device

Deals Of The Year: Cast Your Vote For Top M&A Of 2017

It's time for In Vivo's 10th annual Deal of the Year contest. We've selected 15 nominees in three categories – Top Alliance, Top Financing and Top M&A – and you get to pick the winners. (It's free.)

Deals M & A
See All